tiprankstipranks
Zelira Therapeutics (AU:ZLD)
ASX:ZLD

Zelira Therapeutics (ZLD) Price & Analysis

Compare
5 Followers

ZLD Stock Chart & Stats


---

Financials

Quarterly

ZLD FAQ

What was Zelira Therapeutics’s price range in the past 12 months?
Zelira Therapeutics lowest share price was AU$0.28 and its highest was AU$1.09 in the past 12 months.
    What is Zelira Therapeutics’s market cap?
    Zelira Therapeutics’s market cap is $5.56M.
      When is Zelira Therapeutics’s upcoming earnings report date?
      Zelira Therapeutics’s upcoming earnings report date is Aug 27, 2025 which is in 185 days.
        How were Zelira Therapeutics’s earnings last quarter?
        Currently, no data Available
        Is Zelira Therapeutics overvalued?
        According to Wall Street analysts Zelira Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Zelira Therapeutics pay dividends?
          Zelira Therapeutics does not currently pay dividends.
          What is Zelira Therapeutics’s EPS estimate?
          Zelira Therapeutics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Zelira Therapeutics have?
          Zelira Therapeutics has 11,347,155 shares outstanding.
            What happened to Zelira Therapeutics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Zelira Therapeutics?
            Currently, no hedge funds are holding shares in AU:ZLD
            ---

            Zelira Therapeutics Stock Smart Score

            Company Description

            Zelira Therapeutics

            Zelira Therapeutics Ltd, formerly Zelda Therapeutics Ltd is an Australia-based biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in a breast, brain, and pancreatic cancer.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Cann Group Ltd.
            Epsilon Healthcare Limited
            Althea Group Holdings Ltd.
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis